Trajan Scientific and Medical (Trajan) and University of Tasmania (UTAS) are delighted to secure three top scientists to oversee innovative research programs at ASTech, the ARC Training Centre for Portable Analytical Separation Technologies, supported by the Australian Research Council (ARC).
ASTech is a collaboration between Trajan and UTAS combining industry knowledge and research to innovate in product design, development and manufacturing techniques.
Professor Emily Hilder, ASTech Training Centre Director said that she is looking forward to working closely with the three new Postdoctoral Fellows who were selected from a pool of applicants from around the world.
Dr Greg Barbante has a PhD in Electroanalytical/Synthetic Chemistry and an Honours in the development of sensors based on immobilised microcrystals, and has recent experience in the food industry, including HPLC and GC method development, and project management.
Dr Masoomeh Tehrani Rokh completed her PhD in Engineering in the field of Bio-MicroElectroMechanical Systems (BioMEMS) and microfluidics, a Master of Science in Microengineering and Nanoelectronics, and has extensive experience in microfabrication processes and facilities.
“Dr Barbante and Dr Tehrani Rokh have started at the School of Physical Sciences facilities where I am based at University of Tasmania’s Sandy Bay Campus in Hobart,” said Professor Hilder.
ASTech offers a fantastic career opportunity for researchers which includes unique industry experience. All Postdoctoral Fellows and PhD students will spend one of their three years within industry at Trajan and/or Trajan's partner organisations around the world.
Stephen Tomisich, Trajan’s Chief Executive Officer said, “We are thrilled to have recruited these high calibre researchers for ASTech. Each has unique expertise that will complement R&D at Trajan, and this month we have welcomed Dr Lapierre at Trajan’s global headquarters in Melbourne to commence his industry placement.”
Dr Florian Lapierre has a PhD in Micro and Nanotechnology in the field of sophisticated microfluidic device design, also a Master of Science and Technology in microfluidic systems and a Master of Engineering in scientific measurement and applied business. Florian has worked as an engineer consultant in biomaterial development and designing digital microsystems for pathogen detection.
Mr Tomisich said the development of new micro-materials could play a critical role in next generation portable analytical devices.
“As Trajan make up half of the ASTech Steering Committee, we are pleased to provide an industry perspective, and additional support to ensure we could appoint the best candidates for these senior positions,” said Mr Tomisich.
Professor Hilder encourages scientists to seize the opportunity while ASTech PhD scholarships are still available.
“Applications will be accepted until all HDR positions have been filled, so budding scientists should visit the ASTech website and apply to join us in developing innovative separation technologies,” said Professor Hilder.
Trajan Scientific and Medical
+61 (0) 3 9837 4200
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.